Informations sur le produit
BMS 819881 is a pharmacologic agent that has been shown to improve insulin sensitivity in humans. It is an amide protonated molecule that has potential use for the treatment of obesity and metabolic disorders. BMS 819881 binds to the ATP-binding pocket of the insulin receptor and activates its signaling pathway, leading to enhanced insulin sensitivity. This drug also increases proton conductance through the membrane, which may be due to its effects on ion channels or by enhancing lipid metabolism. Pharmacokinetic studies have demonstrated that BMS 819881 is well-tolerated with a safety profile similar to placebo. Clinical studies have shown that this drug can be achieved at doses as low as 0.5 mg per day, which is lower than other pharmacologic agents used for weight loss.
Propriétés chimiques
Question d’ordre technique sur : 3D-XXB42005 BMS 819881
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
